Abstract: An emulsifiable concentrate formulation for the protection of agricultural crops comprising: (A) a succinate dehydrogenase inhibitor (SDHI) and (B) a phosphoric ester of the formula (R1O)(R2O)(R3O)P?O, wherein R1 represents alkyl having 4 to 12 carbon atoms, or optionally substituted phenyl, and R2 and R3 independently represent alkyl having 2 to 8 carbon atoms, or optionally substituted phenyl. The composition may also comprise surfactants and/or emulsifiers, optionally additional solvents such as esters or amides, and/or an additional fungicide.

Abstract: Novel nucleic acid sequences encoding hemipteran muscarinic receptors, and recombinant expressions and host cells comprising the same are disclosed. Isolated hemipteran muscarinic receptors, host cells expressing hemipteran muscarinic receptors, methods of producing the hemipteran muscarinic receptors and antibodies specific for hemipteran muscarinic receptors are also disclosed. Methods of identifying modulators of hemipterana muscarinic receptors are disclosed.

Abstract: Novel nucleic acid sequences encoding hemipteran myosin light chain kinases are disclosed. Isolated hemipteran myosin light chain kinases are also disclosed.

Abstract: Provided, among other things, is an isolated nucleic acid encoding a GABA-gated chloride channel having: (a) a nucleic acid including a sequence encoding a protein sequence of SEQ ID NO: 3, SEQ ID NO: 6 or SEQ ID NO: 8, or a sequence having at least about 85% sequence identity with SEQ ID NO: 3, SEQ ID NO: 6 or SEQ ID NO: 8, or (b) a nucleic acid that hybridizes with a nucleic acid encoding a protein sequence of SEQ ID NO: 3, SEQ ID NO: 6 or SEQ ID NO: 8 or the complementary sequence to SEQ ID NO: 3, SEQ ID NO: 6 or SEQ ID NO: 8, under stringent conditions; or (c) a nucleic acid that hybridizes with a nucleic acid having a sequence of SEQ ID NO: 1, SEQ ID NO: 4 or SEQ ID NO: 7 or the complementary sequence to SEQ ID NO: 1, SEQ ID NO: 4 or SEQ ID NO: 7, under stringent conditions; or (d) a nucleic acid has at least about 85% sequence identity with the coding region of SEQ ID NO: 1, SEQ ID NO: 4 or SEQ ID NO: 7.

Abstract: Disclosed is a method and a pharmaceutical composition for killing mammalian tumor cells by subjecting the cells to light in the presence of a light-activatable tetrapyrrole, in which the improvement comprises treating the cells with a compound which inhibits the enzymatic conversion of protoporphyrinogen to protoporphyrin IX by protoporphyrinogen oxidase in the cells thereby causing a buildup of protoporphyrin IX in the cells. Also disclosed is a method for the production of protoporphyrin IX which comprises growing eukaryotic microalgae in the presence of a protoporphyrinogen oxidase inhibitor.